StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)

Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%

Conmed r&d expenses

Research and development expenses are spending on new products and technology.

Conmed's R&D Expenses for the twelve months ending Sep 30, 2026 was $62.32M, up 15.1% year over year. For fiscal 2025 it was $55.88M, up 2.7% from the year before. Over ten years it grew 7.4% a year on average. The highest annual figure on record is $55.88M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$55.88M+2.7%
FY2024Dec 31, 2024$54.43M+3.5%
FY2023Dec 31, 2023$52.60M+11.6%
FY2022Dec 31, 2022$47.15M+8.2%
FY2021Dec 31, 2021$43.57M+7.6%
FY2020Dec 31, 2020$40.47M-11.0%
FY2019Dec 31, 2019$45.46M+7.8%
FY2018Dec 31, 2018$42.19M+30.6%
FY2017Dec 31, 2017$32.31M+0.2%
FY2016Dec 31, 2016$32.25M+17.6%
FY2015Dec 31, 2015$27.44M-1.2%
FY2014Dec 31, 2014$27.78M+7.5%
FY2013Dec 31, 2013$25.83M-8.4%
FY2012Dec 31, 2012$28.21M-1.5%
FY2011Dec 31, 2011$28.65M-3.4%
FY2010Dec 31, 2010$29.65M-6.9%
FY2009Dec 31, 2009$31.84M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$15.59M+12.1%
Q2 FY2026Jun 30, 2026$15.50M+9.6%
Q1 FY2026Mar 31, 2026$16.33M+26.2%
Q4 FY2025Dec 31, 2025$14.90M+13.1%
Q3 FY2025Sep 30, 2025$13.90M+2.5%
Q2 FY2025Jun 30, 2025$14.14M+0.3%
Q1 FY2025Mar 31, 2025$12.95M-4.8%
Q4 FY2024Dec 31, 2024$13.18M-6.1%
Q3 FY2024Sep 30, 2024$13.56M+8.8%
Q2 FY2024Jun 30, 2024$14.10M+3.9%
Q1 FY2024Mar 31, 2024$13.59M+8.4%
Q4 FY2023Dec 31, 2023$14.03M+14.8%
Q3 FY2023Sep 30, 2023$12.46M-2.4%
Q2 FY2023Jun 30, 2023$13.57M+18.1%
Q1 FY2023Mar 31, 2023$12.54M+17.5%
Q4 FY2022Dec 31, 2022$12.22M+7.6%
Q3 FY2022Sep 30, 2022$12.77M+17.6%
Q2 FY2022Jun 30, 2022$11.49M+1.5%
Q1 FY2022Mar 31, 2022$10.67M+6.4%
Q4 FY2021Dec 31, 2021$11.36M-3.0%
Q3 FY2021Sep 30, 2021$10.86M+9.3%
Q2 FY2021Jun 30, 2021$11.32M+30.1%
Q1 FY2021Mar 31, 2021$10.03M-0.9%
Q4 FY2020Dec 31, 2020$11.72M-3.1%
Q3 FY2020Sep 30, 2020$9.94M-9.5%
Q2 FY2020Jun 30, 2020$8.70M-26.3%
Q1 FY2020Mar 31, 2020$10.12M-4.3%
Q4 FY2019Dec 31, 2019$12.09M+16.6%
Q3 FY2019Sep 30, 2019$10.99M-22.2%
Q2 FY2019Jun 30, 2019$11.81M+18.2%
Q1 FY2019Mar 31, 2019$10.58M+37.1%
Q4 FY2018Dec 31, 2018$10.37M+23.8%
Q3 FY2018Sep 30, 2018$14.12M+70.8%
Q2 FY2018Jun 30, 2018$9.99M+24.2%
Q1 FY2018Mar 31, 2018$7.71M+1.2%
Q4 FY2017Dec 31, 2017$8.38M+9.7%
Q3 FY2017Sep 30, 2017$8.27M–
Q2 FY2017Jun 30, 2017$8.04M–
Q1 FY2017Mar 31, 2017$7.62M–
Q4 FY2016Dec 31, 2016$7.63M–

More Conmed figures

See a number that looks wrong?